Tags : Triferic

Insights+

Insights+: The US FDA New Drug Approvals in March and

The US FDA’s Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) have approved 48 new products so far in 2019. However, there is a significant increase in multiple diseases while the new approvals are helping and advancing the changes to understand, diagnose, and treat the diseases Our team […]Read More

Pharma

Sun Pharma Signs a License Agreement with Rockwell Medical for

Shots: Rockwell to receive up front, milestones and royalties on sales of Triferic. Sun Pharma to get an exclusive right to develop & commercialize Triferic, following its approval in India  Sun Pharma will be responsible for all clinical, regulatory and commercialization activities of Triferic in India. The collaboration allows Sun Pharma to expand its portfolio […]Read More